Not applicableActive Not RecruitingNCT05179824What this trial is testingTempus Priority Study: A Pan-tumor Observational StudyWho this might be right forBreast CancerProstate CancerBladder Cancer+24 more Tempus AI 1,000
Testing effectiveness (Phase 2)Study completedNCT01246960What this trial is testingRamucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerWho this might be right forStomach CancerEsophageal Cancer Eli Lilly and Company 168
Not applicableUnknownNCT03962244What this trial is testingStent Therapy Versus Endoscopic Vacuum Therapy for Anastomotic Leaks After EsophagectomyWho this might be right forLeaks, Anastomotic University Hospital of Cologne 40
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Not applicableLooking for participantsNCT06346054What this trial is testingMolecular Assessment for Gastro-Esophageal CancerWho this might be right forEsophageal CancerGastric CancerBarrett Esophagus KU Leuven 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06008054What this trial is testingSI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsWho this might be right forEsophageal CancerGastric CancerColorectal Cancer Sichuan Baili Pharmaceutical Co., Ltd. 376
Early research (Phase 1)Study completedNCT00942175What this trial is testingThe Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.Who this might be right forHealthy Takeda 160
Testing effectiveness (Phase 2)Ended earlyNCT01774851What this trial is testingMM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and StomachWho this might be right forHER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more Merrimack Pharmaceuticals 84
Large-scale testing (Phase 3)Ended earlyNCT01697072What this trial is testingFirst-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric Cancer Amgen 609
Not applicableActive Not RecruitingNCT04878783What this trial is testingRadiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRGWho this might be right forGastric CancerAdenocarcinoma of the Stomach University of Roma La Sapienza 138
Not applicableStudy completedNCT02158286What this trial is testingParacetamol Absorption Technique as a Method for Measuring Gastric Tube OutletWho this might be right forEsophageal and/or Cardia CancerEsophagectomyGastric Pull-up Reconstruction Region Skane 13
Early research (Phase 1)Looking for participantsNCT06657144What this trial is testingCHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Coherus Oncology, Inc. 154
Not applicableUnknownNCT03835663What this trial is testingThe Bacterial Composition of the Stomach in Reflux DiseaseWho this might be right forGORDOesophageal CancerOesophageal Reflux+5 more Imperial College London 100
Testing effectiveness (Phase 2)Study completedNCT01498289What this trial is testingS1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer SWOG Cancer Research Network 213
Early research (Phase 1)Active Not RecruitingNCT05462717What this trial is testingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more Revolution Medicines, Inc. 222
Not applicableUnknownNCT02607826What this trial is testingShort-term Starvation vs. Normal Diet Before Chemotherapy of Solid TumorsWho this might be right forCholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more University Hospital Tuebingen 298
Testing effectiveness (Phase 2)Study completedNCT00054873What this trial is testingTezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerWho this might be right forEsophageal NeoplasmsStomach NeoplasmsAdenocarcinoma Chiron Corporation
Early research (Phase 1)Study completedNCT00094003What this trial is testingStudy of NS-9 in Patients With Liver MetastasesWho this might be right forLiver NeoplasmsNeoplasm MetastasisLocal Neoplasm Recurrences NS Pharma, Inc. 20
Not applicableUnknownNCT06475170What this trial is testingPreliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal GastrectomyWho this might be right forGastric CancerReflux Esophagitis Northern Jiangsu People's Hospital 60
Not applicableLooking for participantsNCT07660627What this trial is testingDetermining Minimal Residual Disease Using ctDNA Deep SequencingWho this might be right forEsophageal AdenocarcinomaGastric CancerPancreatic Cancer Masaryk Memorial Cancer Institute 34